Neo Ivy Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,944	Closed	-$470K	–	330
2023 Q3	$470K	Buy	+15,944	New	+$470K	0.21%	173
2022 Q2	–	Sell	-4,992	Closed	-$184K	–	450
2022 Q1	$184K	Sell	4,992 -2,504	-33%	-$92.3K	0.17%	218
2021 Q4	$342K	Buy	+7,496	New	+$342K	0.49%	62